Lataa...
Liquid biopsy for lung cancer early detection
Molecularly targeted therapies and immune checkpoint inhibitors have markedly improved the therapeutic management of advanced lung cancer. However, it still remains the leading cause of cancer-related mortality worldwide, with disease stage at diagnosis representing the main prognostic factor. Detec...
Tallennettuna:
| Julkaisussa: | J Thorac Dis |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5945693/ https://ncbi.nlm.nih.gov/pubmed/29780635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.03.81 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|